| Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer (NCT04399876) | Brigham and Women's Hospital | 2020-06-22 |
| Artificial Intelligence for Prostate Cancer Treatment Planning (NCT04441775) | Dartmouth-Hitchcock Medical Center | 2020-06-22 |
| Retrospective Evaluation of Commercial Spacers in Prostate Cancer Patients (NCT05354427) | BioProtect | 2020-06-18 |
| Evaluation Protocols for Isolation of Analytes From Urine for Future Oncology Applications (NCT05453604) | Novosanis NV | 2020-06-18 |
| Cost Talk: Discussing Cancer Care Costs (NCT04397016) | Washington University School of Medicine | 2020-06-12 |
| Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating Factor (NCT04545632) | Boryung Pharmaceutical Co., Ltd | 2020-06-10 |
| PET/MR for Prostate Cancer Restaging: a Phase II Prospective Monocentric Study (NCT05806853) | IRCCS San Raffaele | 2020-06-03 |
| INTREPId (INTermediate Risk Erection PreservatIon Trial) (NCT04025372) | Brigham and Women's Hospital | 2020-06-01 |
| Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients (NCT04261777) | Saving Patients' Lives Medical B.V. | 2020-05-27 |
| Quality of Life in Prostate Cancer Patients (NCT04357925) | University Hospital Center of Martinique | 2020-05-06 |
| High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy (NCT06982469) | Clinica Universidad de Navarra, Universidad de Navarra | 2020-05-05 |
| Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer Recurrence (NCT04186845) | Blue Earth Diagnostics | 2020-05-04 |
| Open Radical Prostatectomy and Erector Spinae Plane Block (NCT04337060) | BURHAN DOST | 2020-05-01 |
| Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing (NCT04404894) | Myriad Genetic Laboratories, Inc. | 2020-04-30 |
| Conventional Androgen Deprivation Therapy (ADT) With or Without Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADT (NCT03777982) | Dana-Farber Cancer Institute | 2020-04-20 |
| Feasibility and Safety of Physical Exercise in Men With Prostate Cancer (NCT04500080) | Azienda USL Reggio Emilia - IRCCS | 2020-04-14 |
| Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0 (NCT04045717) | Universitaire Ziekenhuizen KU Leuven | 2020-04-10 |
| Combination of 68Ga-PSMA PET Data With Magnetic Resonance Spectroscopy Data (MRS) for Evaluating Prostate Cancer (NCT04154280) | Tel-Aviv Sourasky Medical Center | 2020-04-10 |
| Ablation of Prostate Tissue Utilizing Sterile Water Vapor in Patients With Intermediate Risk Localized Prostate Cancer (NCT04087980) | Francis Medical Inc. | 2020-04-10 |
| 18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate Cancer (NCT04390880) | VA Greater Los Angeles Healthcare System | 2020-04-07 |
| Screening for Prostate Cancer Among Those Prostate-specific Antigen Value Between 2.5 and 4.0 ng/mL (NCT04317625) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2020-04-01 |
| Combined Prostate-specific Antigen, Multi-parametric MRI and Targeted Prostate Biopsy for Prostate Cancer Screening (NCT04322045) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2020-04-01 |
| Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (NCT04136353) | University of Sydney | 2020-03-31 |
| Addition of Opaganib to Androgen Antagonists in Patients With mCRPC (NCT04207255) | Medical University of South Carolina | 2020-03-27 |
| MR-target Biopsy vs. TRUS-biopsy in Men With Suspicious Prostate Cancer (NCT04320147) | Asan Medical Center | 2020-03-23 |
| Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy (NCT04302454) | University Medical Center Groningen | 2020-03-19 |
| Online Trial Examining Validity and Reliability of the Shared Decision Making Process Survey (NCT04317690) | Massachusetts General Hospital | 2020-03-17 |
| Immediate Prostatectomy vs. Cabozantinib Followed by Prostatectomy in Men With High-Risk Prostate Cancer (NCT03964337) | Duke University | 2020-03-17 |
| ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy Setting (NCT04357717) | Exosome Diagnostics, Inc. | 2020-03-15 |
| Technetium Based Radioguided Surgery for Prostate Cancer (TRACE) Study (NCT03857113) | The Netherlands Cancer Institute | 2020-03-11 |
| Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer (NCT03488810) | European Organisation for Research and Treatment of Cancer - EORTC | 2020-03-10 |
| Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer (NCT04221542) | Amgen | 2020-03-04 |
| Needle Localization During Prostate Brachytherapy Using Power Doppler Ultrasound (NCT03861507) | Western University, Canada | 2020-03-04 |
| Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health (NCT04000880) | University of Alabama at Birmingham | 2020-03-04 |
| Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer. (NCT04186819) | Blue Earth Diagnostics | 2020-03-02 |
| Real-life Study of Patients After 3-months of Leuprorelin 5mg Implant in Prostate Cancer (NCT03990194) | RECORDATI GROUP | 2020-03-01 |
| FOCAL HIGH-INTENSITY FOCUSED ULTRASOUND FOR PRIMARY LOCALIZED PROSTATE CANCER: MIDTERM ONCOLOGICAL OUTCOMES (NCT04602208) | Hospices Civils de Lyon | 2020-03-01 |
| Improving Decision-Making for Low Health Literate Prostate CA Patients (NCT05800483) | Northwell Health | 2020-03-01 |
| Acupuncture With Press Tack Needles for Perioperative Pain After Open Radical Prostatectomy (NCT04172649) | Martini-Klinik am UKE GmbH | 2020-03-01 |
| Streamlined Genetic Testing in Prostate Cancer (NCT04359758) | Georgetown University | 2020-03-01 |
| P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) (NCT04249947) | Poseida Therapeutics, Inc. | 2020-02-28 |
| Hemopatch to Prevent Lymphatic Leak After Robotic Prostatectomy and Pelvic Lymph Node Dissection (NCT04185922) | Chinese University of Hong Kong | 2020-02-27 |
| Diffusion Basis Spectrum Imaging of the Prostate (NCT04420702) | Washington University School of Medicine | 2020-02-27 |
| Interactive Decision Aid for Men Diagnosed With Prostate Cancer (NCT04260737) | Reykjavik University | 2020-02-26 |
| Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer (NCT04301414) | Columbia University | 2020-02-25 |
| Study to Gather Information About the Use of Healthcare Services and the Way the Disease is Cared for in Canadian Patients With Prostate Gland Cancer Which Spread Throughout the Body (NCT04281147) | Bayer | 2020-02-24 |
| Immune Profiling After HDR in Local Relapsed Prostate Cancer (NCT04247217) | Maastricht Radiation Oncology | 2020-02-19 |
| bpMRI and Risk Based Shared Clinical Decision Making in Prostate Cancer Diagnosis (NCT04287088) | Turku University Hospital | 2020-02-17 |
| Prostate Cancer Genetic Risk Evaluation and Screening Study (NCT05129605) | Massachusetts General Hospital | 2020-02-12 |
| Use of Pedometer Following Radical Prostatectomy (NCT04206280) | Benaroya Research Institute | 2020-02-10 |
| Trial Comparing Radical Radiotherapy to Prostate Only VS Prostate And Pelvic Lymph Nodes in Intermediate And High Risk Prostate Cancer (NCT05285319) | Cairo University | 2020-02-09 |
| Hypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate Cancer (NCT04197141) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2020-02-07 |
| Utrecht Prostate Cohort for Cancer Treatment Intervention Studies and Long-term Evaluation (NCT04228211) | UMC Utrecht | 2020-02-05 |
| HDR Brachytherapy 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate Cancer (NCT04264208) | Andrei Iagaru | 2020-02-05 |
| Development and Evaluation of a Therapeutic Education Intervention in Prostate Cancer Patients Treated With Radical Prostatectomy to Improve Their Sexuality (NCT03572621) | Hospices Civils de Lyon | 2020-02-03 |
| Effect of Beta-alanine and Pelvic Floor Muscle Training on Urinary Incontinence After Radical Prostatectomy (BELA) (NCT04862533) | University Hospital Olomouc | 2020-02-01 |
| Prostate Cancer in Firemen: Early Diagnosis Because of Increased Diagnostic Pressure? (NCT03896178) | Oslo University Hospital | 2020-02-01 |
| Comparison of PET Imaging Patterns With PSMA and AR Expression in Prostate Cancer and Bladder Cancer (NCT05109884) | Medical University of Vienna | 2020-02-01 |
| EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality (NCT03987633) | Future Genetics Limited | 2020-02-01 |
| PK and Dose Escalation and Expansion Study of DST-2970 (NCT04291664) | DisperSol Technologies, LLC | 2020-01-31 |
| AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft (NCT04263025) | Hackensack Meridian Health | 2020-01-30 |
| A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are Described (NCT04122976) | Bayer | 2020-01-30 |
| Focal Laser Ablation of Prostate Cancer (NCT04305925) | Jonsson Comprehensive Cancer Center | 2020-01-30 |
| RAD 1801: Pilot Study of Intra-Urethral Radiotransponder Beacon Guided Focal Prostate Stereotactic Body Radiotherapy (NCT03458234) | University of Alabama at Birmingham | 2020-01-28 |
| The Role of 68Gallium PSMA-11 in Enhancing Diagnosis of Primary and Metastatic Prostate Cancer (NCT04179968) | Dana Mathews | 2020-01-27 |
| Efficacy and Safety Assessment of IRE of Localized Prostate Cancer (NCT04192890) | I.M. Sechenov First Moscow State Medical University | 2020-01-27 |
| A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer (NCT04094519) | Astellas Pharma Global Development, Inc. | 2020-01-27 |
| Cardiovascular Events in GnRH Agonist vs. Antagonist (NCT04182594) | Rabin Medical Center | 2020-01-17 |
| Serial MRI Scans During Radiation Therapy (NCT04188535) | Dana-Farber Cancer Institute | 2020-01-15 |
| Nivolumab in Biochemically Recurrent dMMR Prostate Cancer (NCT04019964) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-01-13 |
| Neoadjuvant Chemo-hormonal Therapy Combined With Radical Prostatectomy for Locally Advanced Prostate Cancer (NCT04220398) | RenJi Hospital | 2020-01-10 |
| Biomarkers for Neoadjuvant Pembrolizumab in Non-Metastatic Prostate Cancer Positive by 18FDG-PET Scanning (NCT04009967) | CHU de Quebec-Universite Laval | 2020-01-10 |
| Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy (NCT04181203) | UNICANCER | 2020-01-09 |
| The Improving Cancer Aftercare Study. (NCT04163068) | University of Aberdeen | 2020-01-08 |
| Efficacy and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX® (NCT04563936) | Luye Pharma Group Ltd. | 2020-01-06 |
| Prediction Model fo Screening and Diagnosis of Prostate Cancer in PSA Gray Zone Based on Serum PHI Combined With TPV (NCT04251546) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2020-01-04 |
| Aromatherapy on Pain and Anxiety of the Patients Undergoing Prostate Biopsy (NCT06119438) | Mersin Training and Research Hospital | 2020-01-01 |
| Comparison of Multiparametric Prostate MRI and Ga-68 PSMA PET Imaging in Prostate Cancer Staging (NCT05427864) | Gulhane Training and Research Hospital | 2020-01-01 |
| Validation of the Stockholm3 Test for Detection of Prostate Cancer in the Swiss Population (NCT05294627) | University Hospital, Basel, Switzerland | 2020-01-01 |
| Dual-tracer PET Radiomics for Prostate Cancer Stratification (NCT07655648) | Xiangya Hospital of Central South University | 2020-01-01 |
| Prostate SABR With Intra-Prostatic SABR Boost (NCT04212715) | King Saud University | 2019-12-26 |
| Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions (NCT03998657) | InSightec | 2019-12-19 |
| PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy) (NCT04382898) | BioNTech SE | 2019-12-19 |
| OPTimizing Treatment Focused Genetic Testing IN Cancer (NCT04066361) | Dana-Farber Cancer Institute | 2019-12-19 |
| PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores (NCT03495427) | H. Lee Moffitt Cancer Center and Research Institute | 2019-12-18 |
| Prostate Cancer - Patient Empowerment Program (NCT03660085) | Nova Scotia Health Authority | 2019-12-18 |
| Molecular Imaging of Prostate Cancer Using Radiofluorinated PSMA Ligand (NCT04266392) | Stony Brook University | 2019-12-16 |
| Comparative Health Research Outcomes of NOvel Surgery in Prostate Cancer (NCT04049747) | Imperial College London | 2019-12-11 |
| Sarcopenia in Older Patient With Prostate Cancer, Prevalence and Incidence After Androgen Deprivation Therapy (NCT04484246) | Assistance Publique Hopitaux De Marseille | 2019-12-11 |
| An Intimacy Intervention for Couples Completing Breast or Prostate Cancer (NCT04221607) | Brown University | 2019-12-09 |
| Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA (NCT04197414) | Yonsei University | 2019-12-06 |
| Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer (NCT03976843) | National Cancer Institute (NCI) | 2019-12-04 |
| 12 Fractions Carbon Ion Radiotherapy for Localized Prostate Cancer (NCT04724577) | Shanghai Proton and Heavy Ion Center | 2019-12-01 |
| Prostatic Urethral Lift (PUL) Pre-/Post-Radiation Treatment for Prostate Cancer (NCT03817216) | Case Comprehensive Cancer Center | 2019-12-01 |
| Effect of Peritoneal Fixation on Lymphocele Formation (NCT04853095) | University Hospital Olomouc | 2019-12-01 |
| Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour (NCT04107142) | CytoMed Therapeutics Pte Ltd | 2019-12-01 |
| Educational Program Plus Physiotherapy After Prostatectomy (NCT04284020) | University of Alcala | 2019-12-01 |
| Identification of Clinically Insignificant or Significant Prostate Cancer With the miR Scientific Sentinel™ Platform (NCT04100811) | miR Scientific LLC | 2019-12-01 |
| Applying PET/MR in Oncology - a Prospective Project (NCT04158414) | Tel-Aviv Sourasky Medical Center | 2019-11-28 |
| Evaluating Race Specific AGE Accumulation As a Behavioral Biomarker Prostate Cancer Survivors (NCT03459755) | Medical University of South Carolina | 2019-11-27 |